Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis

References

• Augustin M, Glaeske G, Radtke MA, et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162:633–6.
   PubMed Web of Science ®Google Scholar
• Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med. 2009;122:1150.e1–9.
   Web of Science ®Google Scholar
• Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin. 2015;33:41–55.
   PubMed Web of Science ®Google Scholar
• Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol. 2012;132:556–62.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series 2000;894:1–253.
   Google Scholar
• World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 1995;854:1–452.
   Google Scholar
• WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet. 2004;363:157–163.
   Google Scholar
• Herédi E, Csordás A, Clemens M, et al. The prevalence of obesity is increased in patients with late compared with early onset psoriasis. Ann Epidemiol. 2013;23:688–9.
   PubMed Web of Science ®Google Scholar
• Bremmer S, Van Voorhees AS, Hsu S, et al. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;63:1058–69.
   PubMed Web of Science ®Google Scholar
• Engin B, Kutlubay Z, Yardimci G, et al. Evaluation of body composition parameters in patients with psoriasis. Int J Dermatol. 2014;53:1468–73.
   PubMed Web of Science ®Google Scholar
• Mallbris L, Granath F, Hamstem A, Stahle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54:614–21.
   PubMed Web of Science ®Google Scholar
• Davidovici BB, Sattar N, Prinz J, et al. Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010;137:1785–96.
   Web of Science ®Google Scholar
• Coimbra S, Oliveira H, Reis F, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol. 2010;24:789–96.
   PubMed Web of Science ®Google Scholar
• Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes. 2008;32:959–66.
   PubMed Web of Science ®Google Scholar
• Fleming TR, De Mets DL. Surrogate end points in clinical trials: are we being misled?. Ann Intern Med. 1996;125:605–13.
   PubMed Web of Science ®Google Scholar
• Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity (Silver Spring). 2010;18:865–71.
   PubMed Web of Science ®Google Scholar
• Segal KR, Van Loan M, Fitzgerald PI, et al. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr. 1988;47:7–14.
   PubMed Web of Science ®Google Scholar
• Mascie-Taylor CGN, Goto R. Human variation and body mass index: a review of the universality of BMI cut-offs, gender and urban-rural differences, and secular changes. J Physiol Anthropol. 2007;26:109–12.
   PubMedGoogle Scholar
• Lewitt A, Mądro E, Krupienicz A. Theoretical foundations and practical applications of bioelectrical impedance analysis (BIA). Endokrynol Otyłość. 2007;3:79–84.
   Google Scholar
• Dehghan M, Merchant AT. Is bioelectrical impedance accurate for use in large epidemiological studies? Nutr J. 2008;9:7–26.
   Google Scholar
• Barrea L, Balato N, Di Somma C, et al. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? J Transl Med. 2015;13:18–8.
   PubMed Web of Science ®Google Scholar
• Piccoli A, Brunani A, Savia G, et al. Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes Relat Metabol Disord. 1998;22:97–104.
   PubMed Web of Science ®Google Scholar
• Deurenberg P, Yap M, Van Stevens WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998;22:1164–71.
   PubMed Web of Science ®Google Scholar
• De Lorenzo A, Deurenberg P, Pietrantuono M, et al. How fat is obese? Acta Diabetol. 2003;40:S254–S7.
   PubMed Web of Science ®Google Scholar
• De Lorenzo A, Del Gobbo V, Premrov MG, et al. Normal-weight obese syndrome: early inflammation? Am J Clin Nutr. 2007;85:40–5.
   PubMed Web of Science ®Google Scholar
• Naldi L, Addis A, Chimenti S, et al. Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology (Basel). 2008;217:365–73.
   PubMed Web of Science ®Google Scholar
• Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141:1527–34.
   PubMed Web of Science ®Google Scholar
• Fleischer AB. Jr., Characterization of obesity rates for dermatologic ambulatory office visits to United States physicians. J Dermatolog Treat. 2016; 31:1–5.
   Web of Science ®Google Scholar
• Thibault R, Pichard C. The evaluation of body composition: a useful tool for clinical practice. Ann Nutr Metab. 2012;60:6–16.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Dong SY, Sun XN, et al. Percent body fat is a better predictor of cardiovascular risk factors than body mass index. Braz J Med Biol Res. 2012;45:591–600.
   PubMed Web of Science ®Google Scholar
• Deurenberg-Yap M, Chew SK, Deurenberg P. Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev. 2002;3:209–15.
   PubMedGoogle Scholar
• Cruz P, Johnson BD, Karpinski SC, et al. Validity of weight loss to estimate improvement in body composition in individuals attending a wellness center. Obesity (Silver Spring). 2011;19:2274–9.
   PubMed Web of Science ®Google Scholar
• Wright CM, Sherriff A, Ward SC, et al. Development of bioelectrical impedance-derived indices of fat and fat-free mass for assessment of nutritional status in childhood. Eur J Clin Nutr. 2008;62:210–7.
   PubMed Web of Science ®Google Scholar
• Bintvibok W, Cbaikittisilpa S, Panyakamlerd K, et al. Cut-off value of body fat in association with metabolic syndrome in Thai peri- and postmenopausal women. Climacteric. 2013;16:393–7.
   PubMed Web of Science ®Google Scholar
• Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc. 2005;64:163–9.
   PubMed Web of Science ®Google Scholar
• Albareda M, Ravella A, Castelló M, et al. Metabolic syndrome and its components in patients with psoriasis. Springerplus. 2014;3:612.
   PubMed Web of Science ®Google Scholar
• Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99:237–42.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–9.
   PubMed Web of Science ®Google Scholar
• Beygi S, Lajevardi V, Abedini R. C-reactive protein in psoriasis: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28:700–11.
   PubMed Web of Science ®Google Scholar